Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonists
作者:Karin Worm、Damian G. Weaver、Rosalyn C. Green、Christopher T. Saeui、Doreen-Marie S. Dulay、William M. Barker、Joel A. Cassel、Gabriel J. Stabley、Robert N. DeHaven、Christopher J. LaBuda、Michael Koblish、Bernice L. Brogdon、Steven A. Smith、Roland E. Dolle
DOI:10.1016/j.bmcl.2009.07.057
日期:2009.9
benzamides were identified as a novel series of cannabinoid receptor ligands. Replacing the sulfonamide functionality and reversing the original carboxamide bond led to the discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonists. Selective CB2 agonist 31 (Ki = 2.7; CB1/CB2 = 190) displayed robust activity in a rodent model of postoperative pain.